rs73305371

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014855.3(AP5Z1):​c.512-7A>G variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0202 in 1,548,868 control chromosomes in the GnomAD database, including 2,858 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.080 ( 1481 hom., cov: 33)
Exomes 𝑓: 0.014 ( 1377 hom. )

Consequence

AP5Z1
NM_014855.3 splice_region, intron

Scores

2
Splicing: ADA: 0.00003628
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -1.57

Publications

4 publications found
Variant links:
Genes affected
AP5Z1 (HGNC:22197): (adaptor related protein complex 5 subunit zeta 1) This gene was identified by genome-wide screen for genes involved in homologous recombination DNA double-strand break repair (HR-DSBR). The encoded protein was found in a complex with other proteins that have a role in HR-DSBR. Knockdown of this gene reduced homologous recombination, and mutations in this gene were found in patients with spastic paraplegia. It was concluded that this gene likely encodes a helicase (PMID:20613862). [provided by RefSeq, Jan 2011]
AP5Z1 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • hereditary spastic paraplegia 48
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 7-4783682-A-G is Benign according to our data. Variant chr7-4783682-A-G is described in ClinVar as Benign. ClinVar VariationId is 360312.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.261 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AP5Z1NM_014855.3 linkc.512-7A>G splice_region_variant, intron_variant Intron 4 of 16 ENST00000649063.2 NP_055670.1
AP5Z1NM_001364858.1 linkc.44-7A>G splice_region_variant, intron_variant Intron 3 of 15 NP_001351787.1
AP5Z1NR_157345.1 linkn.605-7A>G splice_region_variant, intron_variant Intron 4 of 16
AP5Z1XM_047421098.1 linkc.176-7A>G splice_region_variant, intron_variant Intron 2 of 14 XP_047277054.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AP5Z1ENST00000649063.2 linkc.512-7A>G splice_region_variant, intron_variant Intron 4 of 16 NM_014855.3 ENSP00000497815.1

Frequencies

GnomAD3 genomes
AF:
0.0797
AC:
12123
AN:
152098
Hom.:
1475
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.265
Gnomad AMI
AF:
0.0417
Gnomad AMR
AF:
0.0321
Gnomad ASJ
AF:
0.00288
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00124
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.00663
Gnomad OTH
AF:
0.0675
GnomAD2 exomes
AF:
0.0191
AC:
2945
AN:
154268
AF XY:
0.0156
show subpopulations
Gnomad AFR exome
AF:
0.265
Gnomad AMR exome
AF:
0.0153
Gnomad ASJ exome
AF:
0.00370
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000539
Gnomad NFE exome
AF:
0.00710
Gnomad OTH exome
AF:
0.0147
GnomAD4 exome
AF:
0.0137
AC:
19151
AN:
1396654
Hom.:
1377
Cov.:
32
AF XY:
0.0125
AC XY:
8631
AN XY:
688626
show subpopulations
African (AFR)
AF:
0.282
AC:
8907
AN:
31532
American (AMR)
AF:
0.0191
AC:
679
AN:
35602
Ashkenazi Jewish (ASJ)
AF:
0.00371
AC:
93
AN:
25090
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35684
South Asian (SAS)
AF:
0.00124
AC:
98
AN:
79168
European-Finnish (FIN)
AF:
0.000663
AC:
32
AN:
48300
Middle Eastern (MID)
AF:
0.0109
AC:
62
AN:
5684
European-Non Finnish (NFE)
AF:
0.00731
AC:
7881
AN:
1077686
Other (OTH)
AF:
0.0241
AC:
1398
AN:
57908
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
911
1823
2734
3646
4557
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
452
904
1356
1808
2260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0798
AC:
12148
AN:
152214
Hom.:
1481
Cov.:
33
AF XY:
0.0760
AC XY:
5655
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.265
AC:
11002
AN:
41530
American (AMR)
AF:
0.0320
AC:
490
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00288
AC:
10
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5170
South Asian (SAS)
AF:
0.000828
AC:
4
AN:
4830
European-Finnish (FIN)
AF:
0.000660
AC:
7
AN:
10614
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.00663
AC:
451
AN:
67982
Other (OTH)
AF:
0.0668
AC:
141
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
469
937
1406
1874
2343
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
114
228
342
456
570
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0280
Hom.:
211
Bravo
AF:
0.0921
Asia WGS
AF:
0.0140
AC:
49
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 48 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Dec 05, 2023
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jan 30, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.22
DANN
Benign
0.38
PhyloP100
-1.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000036
dbscSNV1_RF
Benign
0.012
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs73305371; hg19: chr7-4823313; API